Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor

Abstract

Background: MDMA (3, 4-methylenedioxymethamphetamine;“Ecstasy”) is an amphetamine derivative with mild hallucinogenic and stimulant qualities. MDMA leads to serotonin (5-hydroxytryptamine; 5-HT) neurotoxicity and has been linked to cognitive impairments. It …